Literature DB >> 11106545

Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis.

M E Munk, S M Arend, I Brock, T H Ottenhoff, P Andersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11106545     DOI： 10.1086/317663

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  ESAT-6 and CFP-10: what is the diagnosis?

Authors:  Nico C Gey van Pittius; Robin M Warren; Paul D van Helden
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Diagnostic significance of humoral immune responses to recombinant antigens of Mycobacterium tuberculosis in patients with pleural tuberculosis.

Authors:  S Sumi; V V Radhakrishnan
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.

Authors:  Pernille Ravn; Martin E Munk; Ase B Andersen; Bettina Lundgren; Jens D Lundgren; Lars N Nielsen; Axel Kok-Jensen; Peter Andersen; Karin Weldingh
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

5.  Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

Authors:  T Mark Doherty; Abebech Demissie; Joseph Olobo; Dawit Wolday; Sven Britton; Tewodros Eguale; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.

Authors:  S M Arend; A C Engelhard; G Groot; K de Boer; P Andersen; T H Ottenhoff; J T van Dissel
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

8.  Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.

Authors:  Xiao-Qing Liu; Davinder Dosanjh; Hansa Varia; Katie Ewer; Paul Cockle; Geoffrey Pasvol; Ajit Lalvani
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure.

Authors:  Eliane M S Leyten; Bert Mulder; Corine Prins; Karin Weldingh; Peter Andersen; Tom H M Ottenhoff; Jaap T van Dissel; Sandra M Arend
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection.

Authors:  Inger Brock; Karin Weldingh; Eliane M S Leyten; Sandra M Arend; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.